Cover Image
Market Research Report

North America Oligonucleotide Synthesis Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 910507
Published Content info 90 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Oligonucleotide Synthesis Market: Industry Trends and Forecast to 2026
Published: August 1, 2019 Content info: 90 Pages
Description

North America oligonucleotides synthesis market is projected to register a substantial CAGR in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Product Type (DNA Oligonucleotides, RNA Oligonucleotides), Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos), Consumables (Instruments, Kits & Reagents, Others), Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis), Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others), End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others), Country (U.S., Canada, Mexico)

Some of the major factors contributing to the growth of North America oligonucleotides synthesis market:

  • High prevalence rate of obese population in U.S.
  • Increasing R&D expenditure in pharmaceutical and biotechnology companies and rise in venture investments

Market Players

The key market players for North America oligonucleotides synthesis market are listed below:

  • Agilent Technologies, Inc.
  • Atdbio Ltd.
  • LGC Limited
  • Bio-Synthesis Inc.
  • Eurofins Genomics
  • Kaneka Eurogentec S.A.
  • General Electric
  • Genscript
  • AJINOMOTO CO., INC (Genedesign, Inc.)
  • Danaher
  • Merck Kgaa
  • Lgc Biosearch Technologies
  • Nitto Denko
  • Thermo Fisher Scientific
  • Trilink Biotechnologies, Llc
  • Biolytic Lab Performance Inc.
  • Polygen Gmbh
  • Quintara Biosciences
  • Bio Basic Inc.
  • Danaher (Integrated DNA Technologies, Inc)
  • Twist Bioscience
  • Others
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCTS LIFELINE CURVE
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING USAGE OF SYNTHESIZED OLIGOS IN MOLECULAR DIAGNOSTICS AND CLINICAL APPLICATIONS
    • 3.1.2 INCREASING GOVERNMENT INVESTMENTS, R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 3.2 GENETIC DISORDERS
  • 3.3 RESTRAINTS
    • 3.3.1 LACK OF SKILLED PROFESSIONALS
    • 3.3.2 INCREASING IN-HOUSE PRODUCTION HINDERING THE NORTH AMERICA MARKET GROWTH
  • 3.4 OPPORTUNITIES
    • 3.4.1 STRATEGIC INITIATIVES OF THE MARKET PLAYERS
  • 3.5 DEVELOPMENTS AND INNOVATIONS OF NEW PRODUCTS
  • 3.6 CHALLENGES
    • 3.6.1 STRINGENT REGULATIONS
    • 3.6.2 DRUG DELIVERY & TOXICOLOGY CHALLENGES

4 EXECUTIVE SUMMARY

  • 4.1 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026

5 PREMIUM INSIGHTS

6 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2 DNA OLIGONUCLEOTIDES
  • 6.3 RNA OLIGONUCLEOTIDES

7 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 OLIGONUCLEOTIDE-BASED DRUGS
  • 7.3 PRIMERS
  • 7.4 PROBES
  • 7.5 INTERMEDIATE-SCALE SYNTHESIZED OLIGOS
  • 7.6 LARGE-SCALE SYNTHESIZED OLIGOS
  • 7.7 LINKERS & ADAPTORS
  • 7.8 ARRAY-BASED OLIGOS

8 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES

  • 8.1 OVERVIEW
  • 8.2 INSTRUMENTS
  • 8.3 KITS & REAGENTS
  • 8.4 OTHERS

9 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE

  • 9.1 OVERVIEW
  • 9.2 CUSTOM OLIGOS
    • 9.2.1 MODIFICATION
    • 9.2.2 PURIFICATION
  • 9.3 PREDESIGNED OLIGOS
  • 9.4 OLIGO SYNTHESIS
    • 9.4.1 0 NMOL
    • 9.4.2 5,000 NMOL
    • 9.4.3 -200 NMOL
    • 9.4.4 -50 NMOL
    • 9.4.5 000 NMOL
    • 9.4.6 MORE THAN 10,000 NMOL

10 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 RESEARCH APPLICATIONS
    • 10.2.1 PCR
    • 10.2.2 QPCR
    • 10.2.3 SEQUENCING
    • 10.2.4 GENE SYNTHESIS
    • 10.2.5 FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
    • 10.2.6 DNA MICROARRAYS
    • 10.2.7 OTHER APPLICATIONS
  • 10.3 THERAPEUTIC APPLICATIONS
    • 10.3.1 DNA & ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES
    • 10.3.2 RNAI OLIGONUCLEOTIDE-BASED THERAPIES
    • 10.3.3 CPG OLIGONUCLEOTIDE-BASED THERAPIES
    • 10.3.4 OTHERS
  • 10.4 DIAGNOSTIC APPLICATIONS
  • 10.5 OTHERS

11 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER

  • 11.1 OVERVIEW
  • 11.2 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
  • 11.4 CONTRACT RESEARCH ORGANIZATIONS
  • 11.5 HOSPITALS
  • 11.6 OTHERS

12 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY GEOGRAPHY

  • 12.1 NORTH AMERICA
    • 12.1.1 U.S.
    • 12.1.2 CANADA
    • 12.1.3 MEXICO

13 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT & DBMR ANALYSIS

15 COMPANY PROFILE

  • 15.1 DANAHER
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENEUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 MERCK KGAA
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 SERVICE PORTFOLIO
    • 15.2.5 PRODUCT PORTFOLIO
    • 15.2.6 RECENT DEVELOPMENT
  • 15.3 GENERAL ELECTRIC
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENEUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENTS
  • 15.4 THERMO FISHER SCIENTIFIC INC.
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 SERVICE PORTFOLIO
    • 15.4.5 PRODUCT PORTFOLIO
    • 15.4.6 RECENT DEVELOPMENTS
  • 15.5 AGILENT TECHNOLOGIES, INC.
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENTS
  • 15.6 EUROFINS SCIENTIFIC
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 COMPANY SHARE ANALYSIS
    • 15.6.4 SERVICE PORTFOLIO
    • 15.6.5 RECENT DEVELOPMENTS

  • 15.7 ATDBIO LTD.
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 PRODUCT PORTFOLIO
    • 15.7.3 SERVICE PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 AJINOMOTO CO.,INC.
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 REVENUE ANALYSIS
    • 15.8.3 PRODUCT PORTFOLIO
    • 15.8.4 RECENT DEVELOPMENT
  • 15.9 BIANOSCIENCE GMBH
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 PRODUCT PORTFOLIO
    • 15.9.3 RECENT DEVELOPMENT
  • 15.10 BIO BASIC INC
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 SERVICE PORTFOLIO
    • 15.10.3 RECENT DEVELOPMENT
  • 15.11 BIOLYTIC LAB PERFORMANCE INC.
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 PRODUCT PORTFOLIO
    • 15.11.3 RECENT DEVELOPMENTS
  • 15.12 BIO-SYNTHESIS INC
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 SERVICE PORTFOLIO
    • 15.12.3 RECENT DEVELOPMENT
  • 15.13 GENSCRIPT
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENEUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENTS
  • 15.14 KANEKA EUROGENTEC S.A.
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 PRODUCT PORTFOLIO
    • 15.14.3 SERVICE PORTFOLIO
    • 15.14.4 RECENT DEVELOPMENTS
  • 15.15 LGC LIMITED
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 SERVICE PORTFOLIO
    • 15.15.3 PRODUCT PORTFOLIO
    • 15.15.4 RECENT DEVELOPMENTS
  • 15.16 NITTO DENKO CORPORATION
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 REVENUE ANALYSIS
    • 15.16.3 SERVICE PORTFOLIO
    • 15.16.4 RECENT DEVELOPMENTS
  • 15.17 POLYGEN GMBH
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 PRODUCT PORTFOLIO
    • 15.17.3 RECENT DEVELOPMENT
  • 15.18 QIAGEN
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 REVENUE ANALYSIS
    • 15.18.3 PRODUCT PORTFOLIO
    • 15.18.4 RECENT DEVELOPMENTS
  • 15.19 QUINTARA BIOSCIENCES
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 PRODUCT PORTFOLIO
    • 15.19.3 RECENT DEVELOPMENT
  • 15.20 TRILINK BIOTECHNOLOGIES, LLC
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 PRODUCT PORTFOLIO
    • 15.20.3 RECENT DEVELOPMENTS
  • 15.21 TWIST BIOSCIENCE
    • 15.21.1 COMPANY SNAPSHOT
    • 15.21.2 REVENEUE ANALYSIS
    • 15.21.3 PRODUCT PORTFOLIO
    • 15.21.4 RECENT DEVELOPMENTS

16 CONCLUSION

17 QUESTIONNAIRE

18 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 2 NORTH AMERICA DNA OLIGONUCLEOTIDES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 3 NORTH AMERICA RNA OLIGONUCLEOTIDES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 4 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 5 NORTH AMERICA OLIGONUCLEOTIDE-BASED DRUGS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 NORTH AMERICA PRIMERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 NORTH AMERICA PROBES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 NORTH AMERICA INTERMEDIATE-SCALE SYNTHESIZED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 NORTH AMERICA LARGE-SCALE SYNTHESIZED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 NORTH AMERICA LINKERS & ADAPTORS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 11 NORTH AMERICA ARRAY-BASED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)
  • TABLE 13 NORTH AMERICA INSTRUMENTS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 14 NORTH AMERICA KITS & REAGENTS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 NORTH AMERICA OTHERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 17 NORTH AMERICA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 NORTH AMERICA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 19 NORTH AMERICA PREDESIGNED OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 NORTH AMERICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 NORTH AMERICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 22 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 23 NORTH AMERICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 24 NORTH AMERICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 25 NORTH AMERICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 NORTH AMERICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 27 NORTH AMERICA DIAGNOSTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 NORTH AMERICA OTHERS APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 30 NORTH AMERICA BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN OLIGO NUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 NORTH AMERICA ACADEMIC & RESEARCH INSTITUTES IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 33 NORTH AMERICA HOSPITALS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 NORTH AMERICA OTHERS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017- 2026 (USD MILLION)
  • TABLE 36 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 37 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 38 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)
  • TABLE 39 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 40 NORTH AMERICA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 41 NORTH AMERICA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 42 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 NORTH AMERICA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 44 NORTH AMERICA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 45 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 46 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 47 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 48 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)
  • TABLE 49 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 50 U.S. CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 51 U.S. OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 52 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 53 U.S. RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 54 U.S. THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 55 U.S. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 56 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 57 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 58 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)
  • TABLE 59 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 60 CANADA CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 61 CANADA OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 62 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 63 CANADA RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 64 CANADA THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 65 CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 66 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 67 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 68 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY CONSUMABLES, 2017-2026 (USD MILLION)
  • TABLE 69 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 70 MEXICO CUSTOM OLIGOS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 71 MEXICO OLIGO SYNTHESIS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)
  • TABLE 72 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 73 MEXICO RESEARCH APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 74 MEXICO THERAPEUTIC APPLICATIONS IN OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 75 MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIGURE 2 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: NORTH AMERICA VS REGIONAL
  • FIGURE 5 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA OLIGONUCLEOTIDE SYSNTHESIS MARKET
  • FIGURE 9 INCREASING USAGE OF SYNTHESIZED OLIGOS IN MOLECULAR DIAGNOSTICS AND CLINICAL APPLICATIONS AND INCREASING GOVERNMENT INVESTMENTS, R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES AND RISE IN VENTURE INVESTMENTS ARE EXPECTED TO DRIVE THE NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 10 DNA OLIGONUCLEOTIDES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 11 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY PRODUCT TYPE, 2018
  • FIGURE 12 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY TYPE, 2018
  • FIGURE 13 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY CONSUMABLES, 2018
  • FIGURE 14 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY SERVICE TYPE, 2018
  • FIGURE 15 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY APPLICATION, 2018
  • FIGURE 16 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY END USER, 2018
  • FIGURE 17 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: SNAPSHOT (2018)
  • FIGURE 18 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018)
  • FIGURE 19 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 20 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY (2018 & 2026)
  • FIGURE 21 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT TYPE (2018 - 2026)
  • FIGURE 22 NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE 2018 (%)
Back to Top